Background
Acute lung injury (ALI) is a life-threatening hypoxemic respiratory failure showing bilateral infiltrates in the absence of left atrial hypertension [1] , which develops to acute respiratory distress syndrome in the severe stage [2, 3] . Patients with ALI frequently have sepsis and multiple organ failure at the same time. Causes of ALI are divided into direct and indirect injuries, including sepsis, pneumonia, trauma, aspiration, multiple blood transfusions, and drug abuse or overdose [1, [4] [5] [6] . Therapeutic methods benefit from the improvement of mechanical ventilation, and positive-pressure ventilation supplemented with oxygen and positive end-expiratory pressure is necessary for almost all ALI patients [7] . The efficacy and safety of lung recruitment maneuvers and individualized treatment are still under discussion.
Acute and widespread inflammation and tissue fibrosis play vital roles in the development of ALI. Polymorphonuclear neutrophils in the injured lung cannot be eliminated by alveolar macrophages in time, thus producing excess inflammatory factors, including interleukin 1 beta (IL-1b) and tumor necrosis factor alpha (TNF-a) [8] . Other pro-inflammatory factors, such as Toll-like receptor 2 (TLR2), interleukin 6 (IL-6), IL-17, and IL-23, all of which are potential therapeutic targets for treating ALI, also accelerate inflammation and fibrosis and thus aggravate ALI [9] . In addition, lung fibrosis is promoted in the early phase of ALI, manifesting as increased collagen fiber content [10] .
Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine, mainly expressed in skin, gut, lung, and thymus, that plays pivotal roles in regulating T helper 2-mediated inflammation [11] . TSLP and its receptor TSLPR mediate pro-inflammatory cytokines and chemokines release, thus contributing to airway inflammation [12] . Inhibition of mitogen-activated protein kinases (MAPKs) suppresses the IL-1b-induced production of TSLP in endometrioma stromal cells [13] , indicating the association between TSLP and MAPK pathways. However, little is known about the regulatory mechanism of TSLP in pulmonary fibrosis of ALI. In this study we aimed to discover the function of TSLP and the potential mechanism in mediating cell fibrosis in ALI. Human lung fibroblast MRC-5 cells were used and TSLP expression was altered to detect fibrosis indicators, including a-SMA and collagen I. We also analyzed the activation of major MAPKs to discover the possible mechanism of TSLP in cell fibrosis. Our study results add to the evidence of a connection between TSLP and lung cell fibrosis, and provide a potential target for treating lung fibrosis in ALI.
Material and Methods

Cell culture and transfection
Human lung fibroblast MRC-5 cells (ATCC, Manassas, VA) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco, Carlsbad, CA), and maintained in a humidified atmosphere with 5% CO 2 at 37°C.
Cells were seeded in 6-well plates and divided into 4 groups: Control, si-Control, TSLP, and si-TSLP. Transfection was performed in serum-free medium using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Cells in the si-Control and si-TSLP groups were transfected with the negative control for siRNA transfection and the TSLP-specific siRNA designed by RiboBio (Guangzhou, China). For TSLP overexpression in the TSLP group, the coding sequence of TSLP was cloned into pcDNA3.1 vector (TranSheepBio, Shanghai, China) and the vector (50 μM) was transfected into the cells. After the transfection, cells were recovered in complete medium and incubated at 37°C for 48 h before sampling.
Real-time quantitative PCR (qPCR)
Cells of the 4 groups were collected and lysed in TRIzol (Invitrogen) for RNA extraction. The DNA contamination was removed using DNaseI (Invitrogen) and detected by agarose gel electrophoresis. The quantity and quality of RNAs were examined by NanoDrop 2000 (Thermo Scientific, Carlsbad, CA), and 1 μg RNAs of each sample was applied to reverse transcription into complementary DNAs (cDNAs) using the PrimeScript 1 st Strand cDNA Synthesis Kit (TaKaRa, Dalian, China). qPCR was conducted on a LightCycler 480 platform with 20-ng cDNAs and the specific primers for human TSLP (Fw: 5'-TAT GAG TGG GAC CAA AAG TAC CG-3' and Rv: 5'-ACG CCA CAA TCC TTG TAA TTG TG-3') in each reaction. Data were analyzed using 2 -DDCt method with GAPDH (Fw: 5'-GAA GGT GAA GGT CGG AGT C-3' and Rv: 5'-GAA GAT GGT GAT GGG ATT TG-3') as an endogenous reference.
Western blot
Protein samples of the cells were extracted by lysing the cells with radio immunoprecipitation assay lysis buffer (Beyotime, Shanghai, China). The protein samples were quantified using the BCA Protein Assay Kit (Beyotime) and the same amount of samples were loaded for sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Protein bands on the gel were transferred to a polyvinylidene fluoride membrane and blocked in 5% skim milk for 2 h at room temperature and then the blot was incubated in the specific primary antibodies for TSLP (ab47943), skeletal muscle actin (a-SMA, ab5694), collagen I (ab6308), MAPK7 (ab40809), extracellular signal-regulated kinase 1 (ERK1, ab180163), phospho-ERK1 (p-ERK1, ab24157), p38 (ab7952), p-p38 (ab178867), c-Jun N-terminal kinase 1 (JNK1, ab199380), and p-JNK1 (ab47337), purchased from Abcam (Cambridge, UK), overnight at 4°C. b-actin (ab189073) was used as an endogenous reference. After washing, the blot was incubated in horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. Positive signals were developed using the ECL Plus Western Blotting Substrate (Thermo Scientific). Band densities for each sample were analyzed using ImageJ 1.49 software (National Institutes of Health, Bethesda, MD).
Statistical analysis
All experiments were repeated in triplicate and results are indicated as the mean ± standard deviation. P values were calculated by t test in SPSS (IBM, New York, USA) and differences were considered significant at P<0.05.
Results
TSLP promotes a-SMA and collagen I
To analyze the function of TSLP, we performed overexpression and inhibition of TSLP using its specific overexpression vector or siRNA, respectively. qPCR and Western blot analyses were conducted to verify the successful transfection of the vector and siRNA. The TSLP mRNA level in the si-Control group was only slightly changed compared to the Control group (P<0.05), while that of the TSLP group was obviously up-regulated and the si-TSLP group was significantly down-regulated (P<0.001, Figure 1A ). The TSLP protein levels showed similar changing patterns, with no obvious change existing between the Control group and the si-Control group (P<0.05), but significant upregulation and down-regulation were found in the TSLP group and the si-TSLP group (P<0.001, Figure 1B) . These results show the effectiveness of TSLP overexpression and inhibition, and the cells were thus used for further analysis.
Elevated fibrosis is usually accompanied by increased a-SMA and collagen levels; thus, we tested the protein levels of a-SMA and collagen I to evaluate the cell fibrosis. Their expression levels in the si-Control group were nearly unchanged, but were significantly up-regulated when TSLP was overexpressed by its overexpression vector (P<0.001), and inhibited when TSLP was suppressed (P<0.001, Figure 2A , 2B). These data suggest that TSLP can promote the production of a-SMA and collagen I, which appear to indicate the accelerated fibrosis in MRC-5 cells.
TSLP activates MAPK pathways
MAPK pathways have been reported to respond to the cytokines induced by stimuli and promote the production of collagen, thus contributing to fibrosis. Therefore, in this study we analyzed the activation of MAPK pathways by detecting the expression of 4 major MAPKs: MAPK7, ERK1, JNK1, and p38. Western blot results showed that the expression of MAPK7 was significantly promoted by TSLP overexpression, and was inhibited in the si-TSLP group (P<0.001, Figure 3A , 3B). Phosphorylated ERK1, p38, and JNK1 were all promoted by TSLP and inhibited when TSLP was inhibited, and their total protein levels were almost unchanged ( Figure 3A, 3C-3E ), indicating the activation of ERK1, p38, and JNK1 by TSLP. These results suggest that all the major MAPK pathways in mammals are activated by TSLP, which might be the functional mechanism of TSLP in promoting fibrosis in MRC-5 cells.
Discussion
The roles and regulation mechanisms of TSLP in lung fibrosis in ALI have not been previously defined. In this study, we tried to determine them by overexpressing and inhibiting TSLP in human lung fibroblast MRC-5 cells and detecting the expression changes of some key factors. The protein levels of a-SMA and collagen I are up-regulated by TSLP. Further analysis indicates that the major MAPKs are activated by TSLP overexpression.
a-SMA is expressed at higher levels in the epithelial cells and periductular collagen fibers of biliary atresia-induced hepatic fibrosis [14] , and its inhibition attenuates mouse lung fibrosis [15] . Moreover, a hallmark of fibrosis is the accumulation of fibrillary collagens, especially collagen I. Therefore, a-SMA and collagen I are widely used as indicators of fibrosis, including lung fibrosis [16] [17] [18] . In this study, we used these 2 factors to assess the progression of fibrosis in MRC-5. Our findings show that TSLP overexpression significantly up-regulated a-SMA and collagen I levels, both of which were inhibited when TSLP was suppressed. Based on the indicated roles of a-SMA and collagen I in fibrosis, these results suggest that the changes in degree of fibrosis are modulated by TSLP; therefore, TSLP appears to promote MRC-5 cell fibrosis, suggesting its roles in accelerating lung fibrosis in ALI.
MAPKs are serine-threonine kinases that participate in the mediation of various cellular activities [19, 20] . They are mainly divided into 4 subgroups: ERK1/2 MAPK, JNK MAPK, p38 MAPK, and ERK5 MAPK (MAPK7). Other MAPKs, like ERK3/4 and ERK7/8, are poorly understood [20] [21] [22] . MAPKs have been reported to be associated with ALI and other pulmonary diseases [23] . Inhibiting MAPKs can attenuate lipopolysaccharide-induced ALI [24, 25] . With this information, we attempted to analyze the relationship between TSLP and MAPKs in lung fibrosis. Results showed that the expression levels of MAPK7 and the proportion of phosphorylated ERK1, JNK1, and p-38 were all up-regulated by TSLP overexpression, indicating TSLP can activate MAPK pathways in MRC-5 cells. In addition, MAPKs contribute to the progression of fibrosis, as proven in cardiomyopathy [26] and peritoneal fibrosis [27] . Moreover, inhibiting p38 MAPK may attenuate the inflammation and fibrosis of lung diseases [28] . Therefore, it was reasonable to deduce that the activation of MAPK pathways by TSLP might be a potential mechanism of TSLP-induced MRC-5 cell fibrosis. However, the relationship between TSLP and MAPK pathways is complicated, and studies have found that activation of MAPKs can increase TSLP expression [29] . The inter-activation between TSLP and MAPKs might help to amplify the signals during ALI, but this needs further analysis. 
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TSLP inhibition resulted in the down-regulation of a-SMA and collagen I, as well as the less-activated MAPKs, suggesting TSLP is a potential therapeutic target for treating lung fibrosis in ALI. TSLP has been shown to contribute to skin fibrosis in atopic dermatitis [30] and diffuse cutaneous systemic sclerosis [31] . Importantly, a previous study proved that inhibition of TSLP is beneficial in suppressing lung fibrosis; nevertheless, it is achieved through regulating the type I receptor of TGF-b and the downstream SMAD family member 2/3 and JNK, rather than the other MAPKs [32] . It is possible that TSLP regulates various pathways in modulating fibrosis in ALI. It would be of great value if these regulatory pathways were defined in detail and confirmed in further studies. 2361
